» » Loxo Oncology shows high tumor response rates with second genetically targeted cancer drug
Edit

Loxo Oncology shows high tumor response rates with second genetically targeted cancer drug

Loxo Oncology shows high tumor response rates with second genetically targeted cancer drug
  1. Loxo Oncology shows high tumor response rates with second genetically targeted cancer drug  STAT
  2. Loxo Oncology Announces Positive Interim Clinical Data from LOXO-292 Dose Escalation Trial in RET-Altered Cancers ...  GlobeNewswire (press release)Full coverage

Read More ...
Loxo Oncology shows high tumor response rates with second genetically targeted cancer drug published June 02, 2018 at 07:38PM. Original Source Link : https://www.statnews.com/2018/06/02/loxo-oncology-genetic-target/
loading...

0 Response to "Loxo Oncology shows high tumor response rates with second genetically targeted cancer drug"

Posting Komentar

Langganan: Posting Komentar (Atom)